1 of 1
Story summary
- PhRMA appointed former Rep. Eric Cantor (R-Va.) as its president and CEO.
- PhRMA spent a record $38 million lobbying Capitol Hill on drug-price issues.
- Cantor received about $900,000 from pharmaceutical and health-product firms while in Congress, ranking 19th among House candidates 1999-2018.
- He voted against a 2003 bill to import low-cost drugs and a 2007 Medicare price-negotiation proposal.